Suven Life Sciences Ltd.

₹131.99

5.3 (4.1%)

SUVEN Share Price

HEALTHCARE SERVICES

As on January 28, 2026

SectorHealthcare

IndustryHEALTHCARE SERVICES

Basic IndustryHealthcare Research Analytics & Technology

Market Cap₹ 3,031 Cr

P/E Ratio-17.91

Dividend YieldN/A

Trendline Performance

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	133.15	Bearish
10-DMA	141.74	Bearish
20-DMA	153.23	Bearish
50-DMA	164.34	Bearish
100-DMA	185.26	Bearish
200-DMA	202.51	Bearish

Historical Performance

1 Year

14.3%

3 Years

112.9%

5 Years

99.5%

10 Years

-34.9%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	67	117	135	118	135
Total Expenditure	1,723	1,396	1,393	1,341	934
Other Income	109	211	84	16	78
Operating Profit	-1,548	-1,067	-1,173	-1,206	-722
Interest	2	3	4	7	9
Depreciation	58	65	65	44	43
Profit Before Tax	-1,607	-1,061	-1,183	-1,220	-775
Consolidated Net Profit	-1,607	-1,051	-1,183	-1,220	-722
Adjusted EPS	-7	-5	-5	-8	-5

Compounded Sales Growth

10 Years:-58.2

5 Years:-14.3

3 Years:-10.9

TTM:-10.7

Compounded Profit Growth

10 Years:-12.5

5 Years:11.3

3 Years:5.7

TTM:8.9

Stock Price CAGR

10 Years:-4.2

5 Years:15.1

3 Years:28.6

TTM:15.7

Return on Equity

10 Years:5.2

5 Years:-5.2

3 Years:-5.4

last year:-7.4

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	218	218	218	145	127
Total Reserves	869	2,482	3,535	816	584
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	17	13	25	36	45
Other Current Liabilities	166	103	84	54	121
Short Term Borrowings	---	---	---	---	---
Total Liabilities	1,352	2,849	4,828	2,019	2,223
Capital Work in Progress	---	---	---	36	48
Long Term Loans & Advances	---	---	1	3	---
Currents Investments	223	759	463	452	1
Short Term Loans and Advances	128	120	1,089	998	1,412
Total Current Assets	755	2,567	3,455	1,605	1,966
Total Assets	1,352	2,849	4,828	2,019	2,223
Adjusted Book Value	5	12	17	6	6

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a low PE of -17.91, which may indicate undervaluation or subdued growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 29.4%, indicating sustained price appreciation.
The stock carries a beta of 1.0, indicating volatility broadly in line with the market.
In the last financial year, the company reported a negative or negligible EBITDA of ₹-1548 million, indicating weak operating profitability.
In the previous financial year, the company generated revenue of ₹67 million, indicating a relatively small business scale.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1157198

No. of Shares: 8767 (Approx)

Performance:15.7%

P/L: ₹157198

NIFTY Performance: 9.4%

1 day Top Gainers